Lilly 4Q Revenues: $5.2 billion (+22%) 4Q Earnings: $854.4 million (earnings were $132 million 4Q2006)* FY Revenues: $18.6 billion (+19%) FY Earnings: $3.0 billion (+11%) Comments: Sales of Alimta, Byetta, Cialis, Cymbalta, Forteo, Strattera, Symbyax, Xigris and Yentreve collectively grew 55% to $1.7 billion, and accounted for 33% of total 4Q sales, compared with 26% in 4Q06. Zyprexa sales for the quarter were up 10% to $1.3 billion and up 9% FY to $4.8 billion. 4Q Cymbalta sales...